12.43USD+3.84%Mkt Cap: 842.11M $P/E: 30.321d ago
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which compr…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap842.11M $
Enterprise Value1.14B $
Revenue (TTM)576.30M $
Gross Profit388.16M $
Net Income (TTM)22.73M $
Revenue/Share8.609 USD
Last Price12.43 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees940
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)30.32
P/E (Forward)13.69
PEG1.52
EV/EBITDA14.09
EV/Revenue1.98
P/S1.46
P/B4.45
EPS (TTM)0.41
EPS (Forward)0.91
52W Range
5.81099% of range12.53
52W High12.53 USD
52W Low5.810 USD
Profitability
Gross Margin68.33%
Oper. Margin6.73%
EBITDA Margin14.04%
Profit Margin4.00%
ROE12.35%
ROA3.33%
Growth
Revenue Growth6.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF74.67M $
CapEx (TTM)2.56M $
FCF Margin10.99%
FCF Yield7.52%
Net Debt252.57M $
Net Debt/EBITDA3.12
Balance Sheet
Debt/Equity1.60
Current Ratio1.69
Quick Ratio1.06
Book Value/Sh2.793 USD
Cash/Share0.5290 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)14.80 USD
Upside (mean)+19.1%
Target Range14.00 USD – 16.00 USD
$14.00+19.1% to mean$16.00
# Analysts5
Ownership
Shares Out.67.75M
Float33.31M
Insiders11.75%
Institutions78.33%
Short Interest
Short Ratio3.1d
Short % Float4.71%
Short % Out.3.22%
Shares Short2.18M
Short (prev mo.)1.84M
Technical
SMA 509.883 (+25.8%)
SMA 2008.495 (+46.3%)
Beta0.65
S&P 52W Chg20.25%
Avg Vol (30d)675.41K
Avg Vol (10d)779.91K
Technical Indicators
RSI (14)70.0
MACD0.7834
MACD Signal0.5652
MACD Hist.+0.2181
BB Upper13.14 USD
BB Middle10.40 USD
BB Lower7.665 USD
BB Width52.60%
ATR (14)0.5667 USD
Vol Ratio (20d)0.90x